Research and Development cannot stand still. Product portfolios must be continuously evaluated in the light of market forces and new scientific knowledge. New opportunities must be sought. D-MAARSON is already pursuing new products and technologies in both human and veterinary medicine which will provide the engine for its continuing growth.

The research and development department is central to the structure of D-MAARSON. It is responsible for new product development and in addition it supplies technical support throughout the company. The regulatory group forms part of research and development. D-MAARSON recognizes that no matter how good a product is, it must negotiate the regulatory process before there is a benefit to the company and it is D-MAARSON’s policy to ensure the involvement of the regulatory group right from the start.

D-MAARSON’s own in house R&D and regulatory departments have acquired considerable experience in bringing new products to global markets. D-MAARSON’s R&D team, having specialist expertise in drug delivery technologies, is working in state of the art facilities and operating to the highest international standards of Good Laboratory Practice (GLP). This has given D-MAARSON a vital competitive edge in local as well as export market.